Continuation of Aspirin Before Isolated Heart Valve Surgery
NCT ID: NCT05151796
Last Updated: 2021-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2012-05-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aspirin continued within 5 days before surgery
Aspirin
Daily aspirin intake for cardiovascular prevention
Aspirin discontinued more than 5 days before surgery
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aspirin
Daily aspirin intake for cardiovascular prevention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Emergent or salvage surgery
* Surgery for endocarditis
* Use of NSAIDs within 48 hours before surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean François Brichant
Professor of Anesthesia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent Bonhomme, MD, PhD
Role: STUDY_CHAIR
CHU of Liège
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU of Liege
Liège, Liege, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gregory Hans, MD, PhD
Role: primary
Alan Houben, MD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Houben AM, Crepy M, Senard M, Bonhomme V, Tchana-Sato V, Hans G. Preoperative continuation of aspirin before isolated heart valve surgery and postoperative bleeding and transfusion: a single-center retrospective study. Acta Chir Belg. 2024 Aug;124(4):274-280. doi: 10.1080/00015458.2023.2298097. Epub 2023 Dec 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ulganescardio_aspirine
Identifier Type: -
Identifier Source: org_study_id